(Q42204647)

18 October 2017

title

Immunogenicity of intradermal trivalent influenza vaccine with topical imiquimod: a double blind randomized controlled trial (English)

1 reference

18 October 2017

1 reference

3

Kelvin K W To

1 reference

18 October 2017

1

Ivan F N Hung

1 reference

18 October 2017

4

Jasper F W Chan

1 reference

18 October 2017

Vincent Chi Chung Cheng

10

object named as

Vincent C C Cheng

1 reference

18 October 2017

12

Kwok-Yung Yuen

1 reference

18 October 2017

6

Hou-Shun Zhu

1 reference

18 October 2017

9

Tuen-Ching Chan

1 reference

18 October 2017

Anna J Zhang

2

1 reference

18 October 2017

Can Li

5

1 reference

18 October 2017

Patrick Li

7

1 reference

18 October 2017

Clara Li

8

1 reference

18 October 2017

Kwok-Hung Chan

11

1 reference

18 October 2017

language of work or name

English

0 references

publication date

21 July 2014

1 reference

Clinical Infectious Diseases

18 October 2017

published in

1 reference

18 October 2017

volume

59

1 reference

18 October 2017

issue

9

1 reference

18 October 2017

page(s)

1246-1255

1 reference

The impact of influenza on the health and health care utilisation of elderly people.

18 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU582

Two years after pandemic influenza A/2009/H1N1: what have we learned?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU582

Avian influenza A (H5N1) infection in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU582

Human infections with the emerging avian influenza A H7N9 virus from wet market poultry: clinical analysis and characterisation of viral genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU582

Long-term immunogenicity of influenza vaccine among the elderly: Risk factors for poor immune response and persistence

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU582

Selection of an adjuvant for seasonal influenza vaccine in elderly people: modelling immunogenicity from a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU582

Effect of adjuvants on responses to skin immunization by microneedles coated with influenza subunit vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU582

Toll-like receptor 7 agonist imiquimod in combination with influenza vaccine expedites and augments humoral immune responses against influenza A(H1N1)pdm09 virus infection in BALB/c mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU582

Topical delivery of imiquimod to a mouse model as a novel adjuvant for human immunodeficiency virus (HIV) DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU582

Toll like receptor agonists augment HPV 11 E7-specific T cell responses by modulating monocyte-derived dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU582

Enhanced immunogenicity of Plasmodium falciparum peptide vaccines using a topical adjuvant containing a potent synthetic Toll-like receptor 7 agonist, imiquimod

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU582

Effect of clinical and virological parameters on the level of neutralizing antibody against pandemic influenza A virus H1N1 2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU582

Differences in antibody responses of individuals with natural infection and those vaccinated against pandemic H1N1 2009 influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU582

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU582

Concurrent comparison of epidemiology, clinical presentation and outcome between adult patients suffering from the pandemic influenza A (H1N1) 2009 virus and the seasonal influenza A virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU582

Influenza associated mortality in Southern China, 2010-2012.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU582

Clinical Trials of Bivalent Influenza A/New Jersey/76-A/Victoria/75 Vaccines in the Elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU582

Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU582

Microneedle delivery of H5N1 influenza virus-like particles to the skin induces long-lasting B- and T-cell responses in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU582

Age-associated decrease in TLR function in primary human dendritic cells predicts influenza vaccine response

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU582

Changes in human Langerhans cells following intradermal injection of influenza virus-like particle vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU582

Long-term immunogenicity of an AS03-adjuvanted influenza A(H1N1)pdm09 vaccine in young and elderly adults: an observer-blind, randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU582

Superior immunogenicity of inactivated whole virus H5N1 influenza vaccine is primarily controlled by Toll-like receptor signalling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU582

NLRP10 is a NOD-like receptor essential to initiate adaptive immunity by dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU582

Topical resiquimod 0.01% gel decreases herpes simplex virus type 2 genital shedding: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU582

Programming the magnitude and persistence of antibody responses with innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU582

Intradermal hepatitis B vaccination in non-responders after topical application of imiquimod (Aldara).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU582

Dose sparing intradermal trivalent influenza (2010/2011) vaccination overcomes reduced immunogenicity of the 2009 H1N1 strain

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU582

Quantitative and qualitative analysis of antibody response after dose sparing intradermal 2009 H1N1 vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU582

21 January 2018

Identifiers

DOI

10.1093/CID/CIU582

1 reference

18 October 2017

1 reference